What AEC Partners does

AEC Partners SAS is a privately held, France-domiciled boutique strategy consulting firm founded in 1998 and dedicated exclusively to the Life Sciences industry. The company sells four integrated service lines — Strategy & Organization, Business Excellence & Operations, Market Access, and Biotech/Medtech/eHealth Advisory — and serves clients ranging from global pharmaceutical majors (Sanofi, Pfizer, Novartis, Roche, Bristol Myers Squibb) and medical device companies (Medtronic) to biotech startups, academic research institutions (CNRS, Inserm, Institut Pasteur, Gustave Roussy), industry associations (LEEM, SNITEM) and healthcare-focused financial investors (KKR, Wendel, Apax Partners).

The firm is led by a senior partner team drawn from prior roles at BCG, Monitor/Deloitte, IMS Health/IQVIA, Arthur D. Little, and major pharma operators; co-founders Jordi Esclusa and Christine Garnier remain active Managing Partners alongside Lionel Delaporte. It operates from headquarters at 27 avenue Pierre 1er de Serbie, Paris, with additional offices in Singapore (Asia Pacific), New York (North America), and Barcelona (Spain), supplemented by a senior advisor network covering Latin America, the Middle East, and North Africa. Recent engagements include advisory support for the creation of ITCC-P4 gGmbH, a public-private pediatric oncology preclinical testing platform.

Revenue is generated through custom-scoped fee-based consulting engagements, with no disclosed pricing, no external funding, and no M&A activity. The firm has grown organically over 25 years, steadily adding consultant-tier headcount from 2022 through 2025 in specialties such as biotech/medtech advisory and life-sciences market access, while maintaining a flat, partner-collaborative operating model with no parent company or external shareholders.

Name

AEC Partners

Legal name

AEC Partners – SAS 40079505000022

Website

https://aec-partners.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

AEC Partners is a Paris-headquartered boutique strategy consulting firm founded in 1998, exclusively serving the Life Sciences industry across pharmaceuticals, biotech, medtech, and research institutions from offices in Paris, Singapore, New York, and Barcelona.

Ownership category

akta.pro rank

Product category

Life Sciences Consulting

NAICS

Management Consulting Services (54161)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Corporate Strategy Advisory (BPAHADAA)

akta.pro secondary industries

Strategic Partnerships, Alliances & JVs Advisory (BPAHADAI), Corporate Development & Strategic Partnerships Advisory (JVs, Alliances, Carve-outs) (BPAHAOAG)

Keywords

• Life sciences consulting
• Pharmaceutical strategy consulting
• Market access advisory
• Biotech medtech advisory
• Healthcare business transformation

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Strategic Consulting Services: Fee-based consulting engagements for Life Sciences companies including strategy, organization, business excellence, market access, and biotech/medtech advisory services. Revenue is generated through professional services fees for strategic consulting assignments and transactional advisory work.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

AEC Partners provides strategic consulting and transactional advisory services exclusively to the Life Sciences industry. The firm is organized around four service pillars: Strategy & Organization, Business Excellence & Operations, Market Access, and Biotech/Medtech & eHealth Advisory. Engagements are delivered by senior partners and consultants to pharmaceutical, biotech, medtech, eHealth, research, government, and investor clients across global, regional, and local levels.

Product overview

AEC Partners is a strategic consulting and transactions firm for the life sciences industry. The company operates as a single unified consulting practice organized around four core service pillars: Strategy & Organization, Business Excellence & Operations, Market Access, and Biotech/Medtech/eHealth Advisory. These service offerings work together to provide comprehensive consulting support to pharmaceutical, biotech, medtech, and eHealth companies across global, regional, and local levels.

Differentiator

Problem solved

Functional benefit

Products and services

• Strategy & Organization Strategic consulting that brings a strategic vision with organisational and operational performance all along the value chain, for pharmaceutical, biotech, medtech, and eHealth companies.
• Business Excellence & Operations Consulting focused on tackling value creation through new customer engagement model design and operational excellence for life sciences clients.
• Market Access Advisory addressing market access challenges through combined strategic mindset and strong technical capabilities for pharmaceutical and medical device clients.
• Biotech, Medtech & eHealth Advisory Advisory for Biotech, Medtech and eHealth innovators at any stage of their development, including business model definition, business plan, valuation, fundraising, licensing, and partnership strategy.

Named customers18 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• ITCC-P4 gGmbHnotableStrategic or Co-development Partner · 25 May 2023AEC Partners supported the creation of ITCC-P4 gGmbH, the first company in the world to offer preclinical drug testing for paediatric cancers. The new company is a public-private partnership bringing together 11 high-profile research institutions and 3 private companies (Charles River Laboratories, Experimental Pharmacology & Oncology-Berlin-Buch GmbH, and Xentech). ITCC-P4 offers access to 400+ fully characterized paediatric tumour models for systematic efficacy testing.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Bionest Partners: Bionest Partners is a boutique life sciences strategy consulting firm serving pharma, biotech, and medtech clients across therapeutic areas and geographies. It is explicitly referenced in AEC's own team biographies as a prior employer, making it a near-perfect peer in size, scope, and offering.
• ZS Associates: ZS Associates is a global consulting firm exclusively focused on life sciences and pharma, with deep expertise in strategy, market access, and commercial effectiveness. It is the most direct peer to AEC Partners given its single-vertical focus and overlapping service lines in commercial strategy and launch support for pharma/biotech.
• L.E.K. Consulting: L.E.K. Consulting is a global strategy firm with one of the most established healthcare and life sciences practices, advising pharma, biotech, and medtech clients on strategy, M&A, and commercial effectiveness. It directly competes with AEC for senior pharma strategy and biotech advisory engagements.
• Health Advances: Health Advances is a specialized strategy consulting firm exclusively focused on biopharmaceuticals, medical devices, and diagnostics. Its offering in commercial strategy, licensing, and corporate development for life sciences directly mirrors AEC Partners' biotech/medtech advisory practice.
• Simon-Kucher & Partners: Simon-Kucher is a global consulting firm with a strong life sciences practice focused on pricing, market access, and commercial strategy for pharma and medtech. It is a direct competitor in the market access and commercial strategy engagements that AEC delivers.
• Back Bay Life Science Advisors: Back Bay Life Science Advisors is a boutique strategy and transaction advisory firm focused exclusively on life sciences, providing corporate strategy, business development, and financing advisory. Comparable to AEC's Biotech/Medtech/eHealth practice and licensing advisory.
• Charles River Associates (CRA): CRA's Life Sciences practice provides strategy, economic, and litigation consulting to pharma, biotech, and medical device companies globally. It competes with AEC for strategy, M&A due diligence, and commercial advisory work in the life sciences sector.

Broad incumbents

• McKinsey & Company (Healthcare Practice): McKinsey's Pharmaceutical & Medical Products practice is the largest global strategy advisor to pharma and biotech. While offering a much broader portfolio, it competes with AEC for senior pharma strategy and biotech advisory mandates, particularly at the largest global pharma accounts.
• Boston Consulting Group (Healthcare): BCG's Healthcare practice is a global leader in pharma, biotech, and medtech strategy consulting. Several AEC partners are former BCG consultants, and BCG directly competes for large transformation, strategy, and due diligence engagements in life sciences.
• IQVIA (Consulting): IQVIA is the largest life sciences-focused services and data firm, offering consulting, market access, and R&D advisory alongside proprietary data assets. It is the broadest incumbent in the same vertical, competing for strategy and market access mandates but with bundled technology and data advantages AEC cannot match.

Market position

Strengths1 record

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/41707
• Xx.com/aec_partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles19 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AEC Partners